Skip to Main Content

Paper Details

Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial).
Acta Oncol
0
2021

Datasets

Release 1.2